Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
COX-1-sparing NSAIDs--is the enthusiasm justified?
Peterson WL, Cryer B. Peterson WL, et al. Among authors: cryer b. JAMA. 1999 Nov 24;282(20):1961-3. doi: 10.1001/jama.282.20.1961. JAMA. 1999. PMID: 10580464 No abstract available.
Role of seroconversion in confirming cure of Helicobacter pylori infection.
Feldman M, Cryer B, Lee E, Peterson WL. Feldman M, et al. Among authors: cryer b. JAMA. 1998 Jul 22-29;280(4):363-5. doi: 10.1001/jama.280.4.363. JAMA. 1998. PMID: 9686554
A COX-2-specific inhibitor plus a proton-pump inhibitor: is this a reasonable approach to reduction in NSAIDs' GI toxicity?
Cryer B. Cryer B. Am J Gastroenterol. 2006 Apr;101(4):711-3. doi: 10.1111/j.1572-0241.2006.00508.x. Am J Gastroenterol. 2006. PMID: 16635218
COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: is either approach sufficient for patients at highest risk of NSAID-induced ulcers?
Cryer B. Cryer B. Gastroenterology. 2004 Oct;127(4):1256-8. doi: 10.1053/j.gastro.2004.08.029. Gastroenterology. 2004. PMID: 15481002 No abstract available.
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.
Park JY, Dunbar KB, Mitui M, Arnold CA, Lam-Himlin DM, Valasek MA, Thung I, Okwara C, Coss E, Cryer B, Doern CD. Park JY, et al. Among authors: cryer b. Dig Dis Sci. 2016 Aug;61(8):2373-2380. doi: 10.1007/s10620-016-4091-8. Epub 2016 Feb 29. Dig Dis Sci. 2016. PMID: 26923948
Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans.
Feldman M, Shewmake K, Cryer B. Feldman M, et al. Among authors: cryer b. Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G1113-20. doi: 10.1152/ajpgi.2000.279.5.G1113. Am J Physiol Gastrointest Liver Physiol. 2000. PMID: 11053009 Clinical Trial.
Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
Cryer B, Feldman M. Cryer B, et al. Am J Med. 1998 May;104(5):413-21. doi: 10.1016/s0002-9343(98)00091-6. Am J Med. 1998. PMID: 9626023
Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.
Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP. Laine L, et al. Among authors: cryer b. Aliment Pharmacol Ther. 2010 Nov;32(10):1240-8. doi: 10.1111/j.1365-2036.2010.04465.x. Epub 2010 Sep 23. Aliment Pharmacol Ther. 2010. PMID: 20955443 Clinical Trial.
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP; MEDAL Steering Committee. Laine L, et al. Among authors: cryer b. Lancet. 2007 Feb 10;369(9560):465-73. doi: 10.1016/S0140-6736(07)60234-7. Lancet. 2007. PMID: 17292766
A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract.
Chan FK, Cryer B, Goldstein JL, Lanas A, Peura DA, Scheiman JM, Simon LS, Singh G, Stillman MJ, Wilcox CM, Berger MF, Breazna A, Dodge W. Chan FK, et al. Among authors: cryer b. J Rheumatol. 2010 Jan;37(1):167-74. doi: 10.3899/jrheum.090168. Epub 2009 Nov 2. J Rheumatol. 2010. PMID: 19884267
117 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback